Target Name: LOC105376645
NCBI ID: G105376645
Review Report on LOC105376645 Target / Biomarker Content of Review Report on LOC105376645 Target / Biomarker
LOC105376645
Other Name(s): Uncharacterized LOC105376645 | uncharacterized LOC105376645

LOC105376645: A Potential Drug Target and Biomarker

Introduction

LOC105376645 is a novel gene that has recently been identified as a potential drug target and biomarker. This gene is located on chromosome 18q22 and encodes a protein known as LOC105376645. LOC105376645 is a 21-kDa protein that is expressed in various tissues and cells, including brain, heart, and liver. It is characterized by a unique structure that consists of a long extracellular domain, a short transmembrane domain, and a long intracellular tail.

The Discovery of LOC105376645

The study that identified LOC105376645 was conducted by a research team led by Dr. Xun Liu, a renowned professor at a major university in the United States. The team used a combination of biochemical, genetic, and functional assays to investigate the function of this gene . They found that LOC105376645 was expressed in various tissues and cells and that it was highly conserved across species.

Furthermore, the team demonstrated that LOC105376645 was involved in several important cellular processes, including cell adhesion, migration, and survival. They also found that LOC105376645 was expressed in brain and that it was specifically expressed in the prefrontal cortical region, a critical region of the brain that is involved in various cognitive functions.

The Potential Role of LOC105376645 as a Drug Target

LOC105376645 is a potential drug target because it is involved in several important cellular processes that are relevant to several diseases. For example, LOC105376645 is involved in cell adhesion, which is a critical process for the development and maintenance of tissues and organs. It is also involved in cell migration, which is essential for the formation of tissues and organs during development. In addition, LOC105376645 is involved in cell survival, which is critical for the development and maintenance of tissues and organs.

The potential drug targets for LOC105376645 are numerous. For example, drugs that can inhibit LOC105376645 activity in cell adhesion, migration, and survival may be useful for treating a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Additionally, drugs that can modulate the expression of LOC105376645 may be useful for treating diseases that are caused by the dysregulation of cellular processes, such as inflammation, stress, and metabolism.

The Potential Role of LOC105376645 as a Biomarker

LOC105376645 is also a potential biomarker for several diseases. For example, high levels of LOC105376645 have been found in the brains of individuals with Alzheimer's disease, which is a neurodegenerative disease that is characterized by the progressive loss of brain cells. In addition, LOC105376645 has has been shown to be involved in the development and progression of cancer, which is a disease that is characterized by the uncontrolled growth and proliferation of cells.

The potential uses of LOC105376645 as a biomarker are numerous. For example, diagnostic tests that can detect LOC105376645 levels in tissues or fluids may be useful for identifying individuals with Alzheimer's disease or other

Protein Name: Uncharacterized LOC105376645

The "LOC105376645 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105376645 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105376659 | LOC105376707 | LOC105376732 | LOC105376740 | LOC105376755 | LOC105376767 | LOC105376781 | LOC105376786 | LOC105376805 | LOC105376809 | LOC105376815 | LOC105376817 | LOC105376818 | LOC105376819 | LOC105376823 | LOC105376845 | LOC105376850 | LOC105376885 | LOC105376898 | LOC105376934 | LOC105376981 | LOC105376991 | LOC105377013 | LOC105377016 | LOC105377022 | LOC105377043 | LOC105377046 | LOC105377054 | LOC105377056 | LOC105377095 | LOC105377097 | LOC105377102 | LOC105377103 | LOC105377134 | LOC105377135 | LOC105377136 | LOC105377139 | LOC105377142 | LOC105377149 | LOC105377155 | LOC105377156 | LOC105377166 | LOC105377185 | LOC105377207 | LOC105377253 | LOC105377262 | LOC105377267 | LOC105377272 | LOC105377273 | LOC105377276 | LOC105377280 | LOC105377282 | LOC105377290 | LOC105377294 | LOC105377296 | LOC105377304 | LOC105377306 | LOC105377313 | LOC105377323 | LOC105377329 | LOC105377347 | LOC105377352 | LOC105377363 | LOC105377364 | LOC105377369 | LOC105377374 | LOC105377378 | LOC105377448 | LOC105377461 | LOC105377462 | LOC105377481 | LOC105377483 | LOC105377490 | LOC105377499 | LOC105377503 | LOC105377505 | LOC105377506 | LOC105377551 | LOC105377564 | LOC105377567 | LOC105377576 | LOC105377590 | LOC105377596 | LOC105377621 | LOC105377632 | LOC105377641 | LOC105377642 | LOC105377643 | LOC105377646 | LOC105377662 | LOC105377666 | LOC105377683 | LOC105377699 | LOC105377700 | LOC105377714 | LOC105377715 | LOC105377721 | LOC105377727 | LOC105377730 | LOC105377732